Paper TrailKOREA
Why Korean and U.S. stocks moved, checked against filings
· Updated

Three Limit-Up Stocks on Nov 18: Ari Bio Lab +29.98%, and No Company Filing

KOSDAQ rose 1.96%, and three stocks hit the 30% daily limit. Only Ari Bio Lab has a news-reported catalyst, and none of the three has a filing explaining the move.

Three Limit-Up Stocks on Nov 18: Ari Bio Lab +29.98%, and No Company Filing

Seoul — Not a stock recommendation, a record of confirmed facts. Figures as of 16:30 KST, Nov 18, 2026, regular-session close.

stock exchange

Selection criterion: closing at the 30% daily limit (+29.9% or more). KOSDAQ (Korea's tech- and small-cap-heavy market) rose 1.96% to 662.81 and KOSPI rose 1.99% to 5,067.44. Of three limit-up stocks, two (Ari Bio Lab and Big Wave Robotics) have reasons cited in news reports, and none has a filing on DART (Korea's official disclosure system) that explains the move. All three had fallen 15% to 21% the day before and recovered it in a day.

At a glance

Stock Why it rose Nature Basis Heat What to check next
Ari Bio Lab (261780) Reports re-evaluating Phase 3 results for dementia drug AR1001 Expectation Reports only 2/4 overheated Company filing, FDA consultation details
Big Wave Robotics (0035S0) Reports of a robot-theme rally Expectation Reports only 0/4 normal A company filing with a real catalyst
Yeseon Tech (250930) No confirmed reason No reason None 0/4 normal Filings on net loss and listing requirements

Ari Bio Lab (261780): limit-up on reports re-evaluating Phase 3 dementia results, with no company filing

Ari Bio Lab recent price and volume

Ari Bio Lab rose 29.98% to 5,290 won as reports re-assessed the Phase 3 results of AR1001, its oral Alzheimer's drug candidate. Chosun Biz reported that Samjin Pharmaceutical judged the Phase 3 trial a success and will strengthen commercialization cooperation with China's Fosun Pharma, and an Ajunews headline said symptom worsening was delayed 31% in the monotherapy group. News1 reported a push for U.S. FDA approval. All of this is press coverage. The only recent DART filings are the Nov 16 quarterly report and a Nov 11 large-holding report (general) from Ari Bio Holdings, a neutral filing about a stake change. The company itself has not filed anything on the trial results.

The stock fell 20.57% the day before and rebounded, and the 5-day gain is 27.5%. Overheating signals are 2 of 4: volume was 5.4 times the 20-day average and the price sits 31.0% above its 20-day line. It is at 87% of its 52-week range, 9.0% below the high and 67.8% above the 200-day line. It passes 1 of 5 fundamentals checks and is loss-making. No sell orders remained at the close against 437,720 shares of buy orders. The 13:30 gain of 29.73% was nearly the same as the close of 29.98%. Trading value was 72.2 billion won.

Two things to watch: whether the company confirms the reported Phase 3 assessment and FDA consultation in a filing, and whether trading value drops sharply again as it did before the 20% fall.

Big Wave Robotics (0035S0): limit-up on a robot-theme rally, with no company announcement

Big Wave Robotics recent price and volume

Big Wave Robotics rose 29.96% to 17,090 won during a robot-theme rally. Wide Economy's headline said it hit the limit during the 'robot theme tailwind', but the company has filed no catalyst. Recent filings are only the Nov 16 quarterly report and a Nov 13 shareholder meeting notice, both neutral.

It recovered the previous day's 15.85% fall, but is still 56.0% below its 52-week high. Overheating signals are 0 of 4, with RSI at 38.0, 20-day gap of -9.5% and volume 1.3 times average. It passes 1 of 4 fundamentals checks, is loss-making, and revenue fell 3.8%. Buy orders stood at 244,877 shares, trading value was 52.2 billion won, and market cap is 175.7 billion won. It was already at the limit at 13:30, so there was no intraday difference. Foreign investors were net sellers for five straight sessions from Nov 11 to 17.

CBC News also reported a 10%-range rise on Nov 16 on a robot-stock rally, so gains have faded quickly before when the theme cooled. Look for an order or contract filing from the company, and whether trading value stays in the 50 billion won range the next day.

Yeseon Tech (250930): no confirmed reason for the rise

Yeseon Tech recent price and volume

Yeseon Tech rose 29.93% to 1,424 won with no filing and no news report explaining the day's move. Only a Nov 16 quarterly report was filed. Asia Economy reported on Nov 16 that Q3 revenue of 12.1 billion won was up 26% year on year, but that was two days earlier. Jobpost's headline instead read 'net loss after top-line growth, listing requirements to be checked'. The quarterly report is a neutral filing.

The stock hit the limit on Nov 10 and 11, then fell through Nov 17 to 1,096 won before rebounding. Overheating signals are 0 of 4: 28.8% above the 20-day line, volume 2.0 times average. It is 50.7% below its 52-week high and 22.4% below the 200-day line, and passes 3 of 5 fundamentals checks. Market cap is 9.4 billion won, trading value 3.3 billion won, and buy orders 166,689 shares. A July 31 Seoul Credit Rating report discussed expansion into auto and battery materials, but it does not link to today's move.

Watch whether the company explains the rise in a filing and whether net loss and listing-requirement items appear in its filings. With such a small market cap, the last two days show how quickly a move can reverse when trading value falls.

What happened to stocks we covered before

Stock Article date Verdict then Close then Close Nov 18 Change
Optonics 11-17 New listing 17,550 15,140 -13.7%
Gyeyang Electric 11-17 Report 2,935 2,750 -6.3%
Jisen 11-17 Report 6,030 5,190 -13.9%
Namuga 11-16 Report 18,850 16,680 -11.5%
Siseon AI 11-16 Report 3,295 3,020 -8.3%
LK Samyang 11-16 Report 4,735 4,210 -11.1%
Geumho Engineering 11-13 Filing 11,210 10,020 -10.6%
Gaonchips 11-13 Report 38,650 37,250 -3.6%

Even with KOSDAQ up 1.96%, all eight stocks we covered before closed below their level at the time of the article. The six that relied on reports fell between 3.6% and 13.9%, and Geumho Engineering, which had a filing, fell 10.6%.

FAQ

Why did Ari Bio Lab stock go up?

Reports re-evaluating Phase 3 results for dementia drug AR1001. Evidence: Reports only. What to check next: 2/4 overheated.

Why did Big Wave Robotics stock go up?

Reports of a robot-theme rally. Evidence: Reports only. What to check next: 0/4 normal.

Why did Yeseon Tech stock go up?

No confirmed reason. Evidence: None. What to check next: 0/4 normal.

← Latest · Daily movers archive